1 / 1

Stargardt Disease Market Insight, Epidemiology and Market Forecast 2030

Stargardt Disease prevalence is estimated to be 1 in 8,000 to 10,000 individuals.<br>Stargardt Disease is the most commonly inherited childhood and adulthood maculopathy and has Stargardt Disease prevalence of 1 in 10,000.<br>An annual Stargardt Disease incidence in the United Kingdom was between 0.110 and 0.128 per 100 000 individuals.<br><br>To read more visit: https://www.delveinsight.com/report-store/stargardt-disease-stgd-market<br><br>#stargardtdisease #Stargardt

arawat
Download Presentation

Stargardt Disease Market Insight, Epidemiology and Market Forecast 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Stargardt Disease Market Insight, Epidemiology and Market Forecast 2030 Stargardt Disease market key facts ● The estimated prevalence of Stargardt Disease is around 1 in 8,000 to 10,000 individuals. ● In the UK the annual incidence for Stargardt Disease was between 0.110 and 0.128 per 100 000 individuals. ● Stargardt Disease is the most commonly inherited childhood and adulthood maculopathy ● Around 30,000 people in the U.S are affected by Stargardt Disease. Stargardt Disease market report Key benefits ● DelveInsight's " Stargardt Disease Market Insights, Epidemiology, and Market Forecast 2030 report delivers an in-depth understanding of the Stargardt Disease historical and forecasted epidemiology as well as the Stargardt Disease (STGD) market trends in the seven major markets i.e United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ● The STGD market report provides Stargardt Disease current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted Stargardt Disease (STGD) market Size from 2017 to 2030 segmented by seven major markets. ● The Report also covers current Stargardt Disease (STGD) market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. ● The report provides insights into different therapeutic candidates in Stargardt Disease Phase II, and Phase III stage. ● It also analyses Stargardt Disease (STGD) key players involved in developing targeted therapeutics. Some of the key players in the Stargardt Disease market include Astellas Pharma, Acucela Pharmaceuticals, Alkeus Pharmaceuticals and many others. ● The launch of the emerging therapies is expected to significantly impact Stargardt Disease treatment scenario in the upcoming years. Some of the drugs covered in the report include ALK-001, Emixustat, ASP7317 And many others About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

More Related